MoonLake Immunotherapeutics — All Filings
281 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
EFFECT
NT 10-Q
POS AM
PREM14A
PRER14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001821586-26-000002 | Feb 25, 2026 | Dec 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-26-018967 | Feb 23, 2026 | Feb 18, 2026 |
| SCHEDULE 13G | — | 0001172661-26-001033 | Feb 17, 2026 | — |
| 4 | — | 0001213900-26-002907 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | — | 0001213900-26-002906 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | — | 0001213900-26-002905 | Jan 9, 2026 | Jan 7, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-002344 | Jan 8, 2026 | — |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-124519 | Dec 22, 2025 | Dec 19, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-124516 | Dec 22, 2025 | Dec 19, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-124510 | Dec 22, 2025 | Dec 19, 2025 |
| 4 | — | 0001213900-25-120106 | Dec 10, 2025 | Dec 8, 2025 |
| 4 | — | 0001213900-25-120105 | Dec 10, 2025 | Dec 8, 2025 |
| 144 | — | 0001969223-25-001045 | Dec 8, 2025 | — |
| 144 | — | 0001969223-25-001044 | Dec 8, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004943 | Nov 14, 2025 | — |
| SCHEDULE 13G | — | 0001172661-25-004733 | Nov 12, 2025 | — |
| SCHEDULE 13D/A | — | 0000921895-25-002943 | Nov 10, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-106723 | Nov 5, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-106722 | Nov 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002792 | Nov 5, 2025 | — |
| 10-Q | 10-Q | 0001821586-25-000022 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001821586-25-000021 | Nov 5, 2025 | — |
| 4 | — | 0001213900-25-097594 | Oct 9, 2025 | Oct 8, 2025 |
| SCHEDULE 13G/A | — | 0000929638-25-003714 | Oct 1, 2025 | — |
| 4 | — | 0000929638-25-003712 | Oct 1, 2025 | Sep 29, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-092614 | Sep 29, 2025 | — |
| 4 | — | 0001213900-25-084492 | Sep 4, 2025 | Sep 2, 2025 |
| SCHEDULE 13G | — | 0000902664-25-003575 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002044 | Aug 6, 2025 | — |
| 10-Q | 10-Q | 0001821586-25-000018 | Aug 5, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001821586-25-000016 | Aug 5, 2025 | — |
| 4 | — | 0001213900-25-061752 | Jul 7, 2025 | Jul 3, 2025 |
| 144 | — | 0001959173-25-004458 | Jul 3, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0000921895-25-001730 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052370 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052368 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052367 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052366 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052365 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-052140 | Jun 6, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | — | 0000080255-25-000373 | May 14, 2025 | — |
| 10-Q | 10-Q | 0001821586-25-000011 | May 12, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001821586-25-000009 | May 12, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-036363 | Apr 29, 2025 | — |
| ARS | ARS | 0001140361-25-014926 | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001140361-25-014925 | Apr 22, 2025 | — |
| DEF 14A | DEF 14A | 0001140361-25-014923 | Apr 22, 2025 | Jun 5, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-028366 | Apr 3, 2025 | Mar 31, 2025 |
| 4 | — | 0001213900-25-019674 | Mar 3, 2025 | Feb 27, 2025 |
| 4 | — | 0001213900-25-019673 | Mar 3, 2025 | Feb 27, 2025 |